Videoconferencing-based Focused Acceptance and Commitment Therapy for Parents of SHCN Children
Launched by CHINESE UNIVERSITY OF HONG KONG · Mar 26, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to support parents who have children with special healthcare needs, like autism or attention deficit hyperactivity disorder (ADHD). The study will use online video sessions to provide a type of therapy called Focused Acceptance and Commitment Therapy (FACT). The goal is to see if this method can help improve the mental well-being of parents over a three-month period.
To participate, you need to be a Cantonese-speaking resident of Hong Kong, at least 21 years old, and living with a child between the ages of 3 to 9 who has special healthcare needs. You should have reliable internet access and be committed to maintaining it during the study. If you join, you can expect to engage in therapy sessions that focus on coping strategies and acceptance to help you manage the challenges of parenting a child with special needs. This trial is currently recruiting participants, so if you meet the criteria and are interested, you may want to consider applying.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cantonese-speaking Hong Kong residents aged ≥21 years;
- • living together with the child who is at preschool/school-age (3-9 years old);
- • adopt the responsibility of taking care of the child;
- • access to reliable Internet access via either computers and/or smartphones and be committed to maintaining internet access for the duration of the intervention
- • In addition, potential eligible parents who respond "yes" to any of the five validated screening questions in the Children with Special Health Care Needs (SHCN) Screener will then be asked the associated follow-up questions to determine whether the child possesses physical, neurodevelopmental/emotional problem(s) that has lasted for at least 12 months. Only children with a positive response(s) to ≥ 1 item in each of the associated follow-up questions will be classified as children with SHCN
- Exclusion Criteria:
- • Parents with cognitive deficiency, severe mental illness and/or disability conditions that interfere with their ability to comprehend the programme's content
- • had substance/alcohol dependency problems,
- • are pregnant;
- • are less than six months postpartum
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Sha Tin, , Hong Kong
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials